Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia.
Noriko KudoHidenaga YamamoriTamaki IshimaKiyotaka NemotoYuka YasudaMichiko FujimotoHirotsugu AzechiTomihisa NiitsuShusuke NumataManabu IkedaMasaomi IyoTetsuro OhmoriMasaki FukunagaYoshiyuki WatanabeKenji HashimotoRyota HashimotoPublished in: Neuropsychopharmacology reports (2020)
Together, these convergent data suggest a possible biological mechanism for schizophrenia, whereby increased MMP-9 levels are associated with cognitive impairment.